Polio

• CLINICAL_TRIALS trial_result · 2022-09-06
  Clinical Trial Update: Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy Adults [Phase 1]

  Phase 1 clinical trial evaluating inactivated poliovirus vaccine (IPV) with or without dmLT challenge in healthy adults; results posted afte…

• CLINICAL_TRIALS trial_result · 2022-04-05
  Clinical Trial Update: DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants [Phase 3]

  Phase 3 clinical trial evaluating DTaP-IPV-HB-PRP-T as a primary series and a second-year booster in HIV-exposed infants (infected and uninf…

• CLINICAL_TRIALS research · 2021-02-18
  Clinical Trial Update: To Develop, Implement and Evaluate the Polio Demonstration Project Comprising of a Community Based Intervention Package for Polio Eradication in Pakistan [Phase 4]

  Phase 4 clinical trial update for a community-based polio eradication intervention in Pakistan, evaluating a demonstration project and its i…

• CLINICAL_TRIALS trial_result · 2020-02-11
  Clinical Trial Update: Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib) [Phase 1, Phase 2]

  Phase Ib/Phase II trial update assessing safety and immunogenicity of a Sabin inactivated poliovirus vaccine.

• CLINICAL_TRIALS research · 2017-11-17
  Clinical Trial Update: Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan [NA]

  This clinical trial update from Aga Khan University evaluates whether mobile phone SMS messages and automated calls can improve vaccine cove…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2017-04-18
  Clinical Trial Update: Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children. [Phase 3]

  Phase 3 trial evaluating the immunogenicity and safety of Boostrix Polio as a booster dose in 5- to 6-year-old children; results have been p…

• CLINICAL_TRIALS trial_result · 2014-01-14
  Clinical Trial Update: Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar® [Phase 2]

  Phase 2 study evaluating PR5I, a pediatric combination vaccine with an enhanced Hepatitis B component, given concomitantly with Prevnar; the…

• EMA withdrawal · 2013-08-23
  EMA Lapsed: Infanrix Penta (Diphtheria toxoid;tetanus toxoid;Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin);poliovirus (inactivated) (type 1 (Mahoney strain), type 2 (MEF-1 strain), type 3 (Saukett strain));hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.

  EMA status indicates Infanrix Penta is lapsed, with the product no longer active in this market.

• CLINICAL_TRIALS trial_result · 2009-07-03
  Clinical Trial Update: Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease

  Clinical trial update on Seroimmunity 2007 and a sub-study of the Swedish population assessing seroprevalence for vaccine-preventable diseas…